Literature DB >> 23901040

A pooled analysis of the outcome of prospective colonoscopic surveillance for familial colorectal cancer.

David Mesher1, Isis Dove-Edwin, Peter Sasieni, Hans Vasen, Inge Bernstein, Brigitte Royer-Pokora, Elke Holinski-Feder, Fiona Lalloo, D Gareth Evans, Anna Forsberg, Annika Lindblom, Huw Thomas.   

Abstract

Surveillance guidelines for the management of familial colorectal cancer (FCC), a dominant family history of colorectal cancer in which the polyposis syndromes and Lynch syndrome have been excluded, are not firmly established. The outcome of colonoscopic surveillance is studied using data from six centers. DNA mismatch repair deficiency was excluded by genetic testing. Families were classified as FCC type X if they fulfilled the original Amsterdam criteria (AC) and late onset (LOFCC) if they fulfilled the AC apart from not having a cancer aged under 50. The most advanced findings on colonoscopy were analyzed. One thousand five hundred eighty-five individuals (median age 47.3, 44% male) from 530 FCC families (349 FCC type X) underwent a total of 4,992 colonoscopies with 7,904 patient-years of follow-up. Results for FCC type X and LOFCC were very similar. At baseline, 22 prevalent asymptomatic colorectal cancers were diagnosed, 120 (7.6%) individuals had high-risk adenomas and 225 (14.2%) simple adenomas. One thousand eighty-eight individuals had a further colonoscopy (median follow-up of 6.2 years). Of nine individuals diagnosed with cancer, eight had a previous history of at least one polyp/adenoma. High-risk adenomas were detected in 92 (8.7%) and multiple adenomas were detected in 20 (1.9%) individuals. Both FCC type X and LOFCC have a high prevalence of colorectal cancers and on follow-up develop high-risk adenomas (including multiple adenomas), but infrequent interval cancers. They should be managed similarly with five-yearly colonoscopies undertaken from between 30 and 40 with more intensive surveillance in individuals developing multiple or high-risk adenomas.
© 2013 UICC.

Entities:  

Keywords:  Amsterdam criteria; colonoscopic surveillance; familial colorectal cancer type X; pooled analysis

Mesh:

Year:  2013        PMID: 23901040     DOI: 10.1002/ijc.28397

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  13 in total

Review 1.  Clinical management of hereditary colorectal cancer syndromes.

Authors:  Hans F A Vasen; Ian Tomlinson; Antoni Castells
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-01-13       Impact factor: 46.802

2.  Communication Among Melanoma Family Members.

Authors:  Deborah J Bowen; Terrance Albrecht; Jennifer Hay; Susan Eggly; Julie Harris-Wei; Hendrika Meischke; Wylie Burke
Journal:  J Health Commun       Date:  2017-02-13

3.  The KinFact intervention - a randomized controlled trial to increase family communication about cancer history.

Authors:  Joann N Bodurtha; Donna McClish; Maria Gyure; Rosalie Corona; Alexander H Krist; Vivian M Rodríguez; Alisa M Maibauer; Joseph Borzelleca; Deborah J Bowen; John M Quillin
Journal:  J Womens Health (Larchmt)       Date:  2014-10       Impact factor: 2.681

4.  Family Attitudes and Communication about Sun Protection and Sun Protection Practices among Young Adult Melanoma Survivors and Their Family Members.

Authors:  Sharon Manne; Deborah A Kashy; Sherry Pagoto; Susan K Peterson; Carolyn J Heckman; Joseph Gallo; Adam Berger; David B Buller; Alexandria Kulik; Sara Frederick; Morgan Pesanelli
Journal:  J Health Commun       Date:  2021-11-29

5.  Risk of multiple colorectal cancer development depends on age and subgroup in individuals with hereditary predisposition.

Authors:  Lars J Lindberg; Wia Wegen-Haitsma; Steen Ladelund; Lars Smith-Hansen; Christina Therkildsen; Inge Bernstein; Mef Nilbert
Journal:  Fam Cancer       Date:  2019-04       Impact factor: 2.375

6.  Guidelines for the management of hereditary colorectal cancer from the British Society of Gastroenterology (BSG)/Association of Coloproctology of Great Britain and Ireland (ACPGBI)/United Kingdom Cancer Genetics Group (UKCGG).

Authors:  Kevin J Monahan; Nicola Bradshaw; Sunil Dolwani; Bianca Desouza; Malcolm G Dunlop; James E East; Mohammad Ilyas; Asha Kaur; Fiona Lalloo; Andrew Latchford; Matthew D Rutter; Ian Tomlinson; Huw J W Thomas; James Hill
Journal:  Gut       Date:  2019-11-28       Impact factor: 23.059

7.  Hereditary cancer registries improve the care of patients with a genetic predisposition to cancer: contributions from the Dutch Lynch syndrome registry.

Authors:  Hans F A Vasen; Mary E Velthuizen; Jan H Kleibeuker; Fred H Menko; Fokke M Nagengast; Annemieke Cats; Andrea E van der Meulen-de Jong; Martijn H Breuning; Anne J Roukema; Inge van Leeuwen-Cornelisse; Wouter H de Vos Tot Nederveen Cappel; Juul T Wijnen
Journal:  Fam Cancer       Date:  2016-07       Impact factor: 2.375

8.  Identification of familial colorectal cancer and hereditary colorectal cancer syndromes through the Dutch population-screening program: results ofa pilot study.

Authors:  Sanne J H van Erp; Laura W Leicher; Simone D Hennink; Zeinab Ghorbanoghli; Simone A C Breg; Hans Morreau; Maartje Nielsen; James C H Hardwick; Jan A Roukema; Alexandra M J Langers; Wouter H de Vos Tot Nederveen Cappel; Hans F A Vasen
Journal:  Scand J Gastroenterol       Date:  2016-06-16       Impact factor: 2.423

9.  Evaluation of a population-based approach to familial colorectal cancer.

Authors:  P S Parfrey; E Dicks; O Parfrey; P J McNicholas; H Noseworthy; M O Woods; C Negriin; J Green
Journal:  Clin Genet       Date:  2017-03-08       Impact factor: 4.438

10.  Decentralized colonoscopic surveillance with high patient compliance prevents hereditary and familial colorectal cancer.

Authors:  Olle Sjöström; Lars Lindholm; Björn Tavelin; Beatrice Melin
Journal:  Fam Cancer       Date:  2016-10       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.